Related references
Note: Only part of the references are listed.
Review
Chemistry, Multidisciplinary
Tao Zhang et al.
Summary: This article discusses the strategies for functionalizing diverse tetrahedral framework nucleic acids (tFNAs) and their potential biomedical applications. tFNAs have the ability to scavenge reactive oxygen species, enhance cellular endocytosis and tissue permeability, and promote cell-material interactions. They can be used to treat inflammatory and degenerative diseases, and also have potential applications in targeted therapies, tissue regeneration, antitumor strategies, and antibacterial treatment through their structural programmability.
ADVANCED MATERIALS
(2022)
Article
Oncology
Rikke Norgaard Pedersen et al.
Summary: Research shows that there is still a risk of breast cancer recurrence up to 32 years after the initial diagnosis. Tumor size larger than 20 mm, lymph node-positive disease, and estrogen receptor-positive tumors are associated with increased risk of late breast cancer recurrence. Women with these characteristics may require extended surveillance, more aggressive treatment, or new therapy approaches.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
(2022)
Review
Pharmacology & Pharmacy
Liang Chen et al.
Summary: This review focuses on the recent progress of framework nucleic acids (FNAs) in the pharmaceutical field, including drug discovery, drug delivery, and drug analysis. FNAs, which are DNA nanostructures with defined size, shape, and functionality, have been widely explored in various fields. The advantages, applications, and limitations of FNAs are discussed, along with an outlook on future pharmaceutical research directions.
ACTA PHARMACEUTICA SINICA B
(2022)
Article
Oncology
Kimberly D. Miller et al.
Summary: The number of cancer survivors in the United States is increasing due to population growth, aging, and improved detection and treatment. The most prevalent cancers are prostate, skin melanoma, and colon and rectum for males, and breast, uterine corpus, and thyroid for females. Treatment disparities exist, with Black patients being less likely to be diagnosed with early-stage cancer and having lower surgical receipt rates.
CA-A CANCER JOURNAL FOR CLINICIANS
(2022)
Review
Nanoscience & Nanotechnology
Yanfei Qu et al.
Summary: In recent years, DNA-based nanoscale or microscale functional materials have shown great potential in immunotherapy as superior delivery carriers. These materials have programmable and addressable structures that enable precise assembly of molecules or nanoparticles. DNA hydrogels with predictable structures and adjustable mechanical strength are advantageous for controlled release of cargos. DNA aptamers have been screened for specific recognition of ions, molecules, and cells using systematic evolution of ligands by exponential enrichment technology. Chemical modifications further enhance the functionalities of DNA. These functional DNA materials have unique advantages in immunomodulation and have shown great potential in fighting against diseases like cancer, viral infection, and inflammation.
ACS APPLIED MATERIALS & INTERFACES
(2022)
Article
Oncology
Angela N. Giaquinto et al.
Summary: This article provides an update on female breast cancer statistics in the United States, including data on incidence, mortality, survival, and mammography screening. It shows that breast cancer incidence rates have increased over the past few decades, driven by localized-stage and hormone receptor-positive disease. However, breast cancer mortality rates have been steadily declining since 1989, although at a slower pace in recent years. Despite lower incidence rates, there remains a racial disparity in breast cancer mortality, with higher rates among Black women compared to White women.
CA-A CANCER JOURNAL FOR CLINICIANS
(2022)
Article
Chemistry, Multidisciplinary
Xiuhai Mao et al.
Summary: Artificial molecular machines have been widely used in various fields, and recent advancements in DNA have led to the development of DNA-based artificial molecular machines. The programmability of DNA allows for the design of complex machines that can exert mechanical force or motion in a controllable and modular manner. This Perspective highlights the potential and strategies for constructing DNA-based molecular machines, and discusses the challenges and opportunities in biophysics, biosensing, and biocomputing.
Review
Oncology
Tanya E. Keenan et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
(2020)
Review
Oncology
Sylvia Adams et al.
Article
Nanoscience & Nanotechnology
Tian Tian et al.
ACS APPLIED MATERIALS & INTERFACES
(2018)
Article
Nanoscience & Nanotechnology
Dawei Jiang et al.
ACS APPLIED MATERIALS & INTERFACES
(2016)
Article
Pharmacology & Pharmacy
Oktay Tacar et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY
(2013)
Article
Biochemistry & Molecular Biology
Abhishek D. Garg et al.
Review
Medicine, Research & Experimental
Fabienne Danhier et al.
MOLECULAR PHARMACEUTICS
(2012)
Review
Oncology
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER
(2012)
Article
Chemistry, Multidisciplinary
Jiang Li et al.
Article
Biochemistry & Molecular Biology
Michel Obeid et al.
Article
Immunology
N Casares et al.
JOURNAL OF EXPERIMENTAL MEDICINE
(2005)
